Company Overview

Company name: The Hydropothecary (TSE: HEXO)
Description: Manufacturer and distributor of medical marijuana created to combine artisanal growing techniques with quality production. The company’s medical marijuana include flower extracts, oil extracts and edibles that are naturally and organically grown, enabling consumers and physicians to use it for medical treatment as well as herbal remedies.
Year founded: 2013
Parent company:
Industry: Business Products and Services (B2B) | Group: Commercial Products | Code:
Website: www.thehydropothecary.com
Employees: 220
City: Gatineau
State: Quebec
Country: Canada
Region: Americas

Financial Highlights

Start up capital raised (USD Million): 131.33
Business status: Profitable
Ownership: Publicly Held
Exchange: TSE
Ticker: HEXO
Revenue (USD Million): 9.64
Gross profit (USD Million): 5.03
Net income (USD Million) -18.33
Enterprise value: 452.64
Earnings before interest, tax, depreciation and amortization (EBITDA): -17.49
Fiscal period: FY 2018
Financing Status: The company (TSXV: THCX) received CAD 149.5 million of development capital from undisclosed investors on January 30, 2018 through a private placement. The company issued a total of 37,375,000 units at CAD 4 per unit. The company intends to use the net proceeds to acquire additional production equipment, further expand and increase the company’s production, processing and distribution capacity, develop distribution channels in the adult recreational use market across Canada, explore international business development opportunities and make strategic investments.
Number of active investors:
Profile last updated: 03-Nov-2018
Last known valuation: 15.02
Last known valuation date: 22-Jan-2016